Superior Group (SGC) Q2 2026 Earnings Call Transcript
Superior Group of Companies (SGC) reported Q2 2026 revenue of $147.8 million, up 3% year over year, with Branded Products revenue rising to $98.4 million. Adjusted diluted EPS was $0.21 versus $0.10, and adjusted EBITDA rose 27% to $7.7 million. The company guided full-year sales to $572-$585 million and adjusted EPS to $0.54-$0.66.
How this was made

The 30-second read
Why it matters
Traders can update 2026 expectations using the reiterated sales and adjusted EPS ranges, while monitoring the stated expectation of continued shorter-term margin pressure through year-end.
Market read
Earnings call transcript provides actionable 2026 guidance ranges and segment margin/cash flow details that can drive near-term positioning.
What to watch
Contact Center growth is described as pipeline-driven with slower RFP decisions; execution risk on the stated acquisition or Philippines facility could delay revenue conversion and keep margins under pressure.
Background
Superior Group of Companies (SGC) discussed Q2 2026 performance across Branded Products, Healthcare Apparel, and Contact Centers, including working capital actions and segment transitions.
Ticker impact
Superior Group of Companies reported Q2 2026 results and confirmed full-year guidance, including adjusted EPS $0.54 to $0.66 and sales $572M to $585M.
Likely modest post-earnings volatility, with focus on whether Healthcare Apparel margin pressure persists and whether Contact Center expansion plans translate into revenue acceleration.
The article provides concrete earnings metrics, segment drivers, and explicit full-year ranges, but it is a transcript-style earnings disclosure without an explicit surprise versus consensus in the text.
Market effects
Signals ongoing normalization in institutional healthcare apparel demand and continued margin sensitivity to inventory and assortment transitions.
No specific regional demand or policy impacts disclosed beyond a Philippines facility plan for Contact Centers.
Limited global relevance; discussion is company-specific with no cross-border regulatory or macro shock described.
Counterpoint
The headline growth is modest (revenue +3%), while gross margin fell and Healthcare Apparel remains loss-making, so the EPS improvement may be partially offset by noncash charges and mix effects.
Key entities
- companySuperior Group of Companies
SGC management reported Q2 2026 results and reiterated full-year 2026 guidance, highlighting segment-level margin and cash flow drivers.
- executiveMichael Benstock
CEO cited ongoing Healthcare Apparel margin pressure and described Contact Centers expansion urgency.
- executiveMichael Koempel
CFO discussed segment margin dynamics, inventory reduction drivers, and Contact Center pipeline conversion.

